Who has the most effective MSLs, and why?

MSL channels are becoming more important to healthcare practitioners, as long as they're done right, a new survey suggests.

Healthcare research company Konovo conducted a survey of 100 oncologists based in the United States in May this year, and learned what separated highly effective MSL teams from average ones.

Leading the pack is AstraZeneca's teams. When asked the unprompted question: "Which pharma/biotech companies have the most effective MSL teams?", 22 named AstraZeneca. The pharma's MSLs earned the place with consistent follow-up, advisory board access, schedule accommodation, and clear clinical correlations.

To see the whole article please log in.

James Quintana Pearce

Log in with your member email for full access.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Email

Retype password

Not a member? Sign up here